Answers are grounded in this paper and cite their sources.
Novel oxygen self-carrying nanoparticles based on substituted diphenyl anthracene and IR780 were developed against tumor hypoxia.
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: